Stock SNCA PALISADE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Palisade Bio, Inc.

Equities

SNCA

US6963894026

Real-time Estimate Cboe BZX
Other stock markets
 12:29:37 2024-05-02 EDT 		5-day change 1st Jan Change
7.355 USD +3.88% Intraday chart for Palisade Bio, Inc. +17.34% -17.40%
05-01 Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts MT
05-01 Palisade Bio?s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. SNCA Stock
  4. Revisions Palisade Bio, Inc.